Literature DB >> 26194650

[Reversible cerebral vasoconstriction syndrome. Challenge for diagnostics and intensive care therapy].

G Jansen1, F Mertzlufft, F Bach.   

Abstract

Reversible cerebral vasoconstriction syndrome (RCVS) is a disease of unclear incidence frequently affecting middle aged women and is usually associated with use of adrenergic or serotoninergic substances. The exclusion of relevant differential diagnoses, such as aneurysmal subarachnoid hemorrhage, primary cerebral angiitis, posterior reversible encephalopathy syndrome and carotid artery dissection is critical in terms of time and significance. Thunderclap headache as well as multiple and multilocular vasospasms with direct or indirect angiography without substantial findings in cerebrospinal fluid diagnostics are typical symptoms. The necessity for intensive care treatment is often justified by initial acute impairment of vital functions and possible development of cerebral or extracerebral complications. Because the exact pathophysiology remains unknown, a specific therapy does not exist. This poses significant challenges in intensive care medicine, which are illustrated on the basis of the case study presented.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26194650     DOI: 10.1007/s00101-015-0053-3

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  9 in total

Review 1.  Narrative review: reversible cerebral vasoconstriction syndromes.

Authors:  Leonard H Calabrese; David W Dodick; Todd J Schwedt; Aneesh B Singhal
Journal:  Ann Intern Med       Date:  2007-01-02       Impact factor: 25.391

Review 2.  Reversible cerebral vasoconstriction syndrome: updates and new perspectives.

Authors:  Huma U Sheikh; Paul G Mathew
Journal:  Curr Pain Headache Rep       Date:  2014-05

3.  Magnetic resonance angiography in reversible cerebral vasoconstriction syndromes.

Authors:  Shih-Pin Chen; Jong-Ling Fuh; Shuu-Jiun Wang; Feng-Chi Chang; Jiing-Feng Lirng; Ying-Chen Fang; Ben-Chang Shia; Jaw-Ching Wu
Journal:  Ann Neurol       Date:  2010-05       Impact factor: 10.422

4.  Reversible cerebral vasoconstriction syndromes: what the cardiologist should know.

Authors:  Aneesh B Singhal
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-03

5.  Recurrent primary thunderclap headache and benign CNS angiopathy: spectra of the same disorder?

Authors:  S-P Chen; J-L Fuh; J-F Lirng; F-C Chang; S-J Wang
Journal:  Neurology       Date:  2006-12-26       Impact factor: 9.910

6.  Reversible cerebral vasoconstriction syndrome: an under-recognized clinical emergency.

Authors:  Shih-Pin Chen; Jong-Ling Fuh; Shuu-Jiun Wang
Journal:  Ther Adv Neurol Disord       Date:  2010-05       Impact factor: 6.570

Review 7.  Reversible cerebral vasoconstriction syndrome.

Authors:  Anne Ducros
Journal:  Lancet Neurol       Date:  2012-10       Impact factor: 44.182

8.  Safety of induced hypertension therapy in patients with acute ischemic stroke.

Authors:  Matthew A Koenig; Romergryko G Geocadin; Megan de Grouchy; James Glasgow; Sangeetha Vimal; Lucas Restrepo; Robert J Wityk
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

9.  Association between hyperoxia and mortality after stroke: a multicenter cohort study.

Authors:  Fred Rincon; Joon Kang; Mitchell Maltenfort; Matthew Vibbert; Jacqueline Urtecho; M Kamran Athar; Jack Jallo; Carissa C Pineda; Diana Tzeng; William McBride; Rodney Bell
Journal:  Crit Care Med       Date:  2014-02       Impact factor: 7.598

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.